These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9715819

  • 21. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ, Yue TL, Cheng HY, Ruffolo RR.
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The early anti-oxidant effect of carvedilol predicts the clinical course in congestive heart failure patients.
    Goldhammer E, Maor I, Shnitzer S, Lanir A, Abinader EG.
    J Cardiovasc Med (Hagerstown); 2007 Jun; 8(6):453-6. PubMed ID: 17502762
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
    Lindenfeld J, Lowes BD, Bristow MR.
    Ann Pharmacother; 1999 Dec; 33(12):1266-9. PubMed ID: 10630826
    [Abstract] [Full Text] [Related]

  • 27. Beta-blockers in heart failure. The 'new wave' of clinical trials.
    Krum H.
    Drugs; 1999 Aug; 58(2):203-10. PubMed ID: 10473016
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Carvedilol--a wide therapeutic potential in cardiovascular syndromes. Introduction.
    Taylor SH, Storstein L.
    Cardiology; 1993 Aug; 82 Suppl 3():1-2. PubMed ID: 8106157
    [No Abstract] [Full Text] [Related]

  • 34. Carvedilol for heart failure: renewed interest in beta blockers.
    Young JB.
    Cleve Clin J Med; 1997 Sep; 64(8):415-22. PubMed ID: 9308217
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Results of therapy with carvedilol, a beta-blocker vasodilator with antioxidant properties, in hypertensive patients.
    Moser M, Frishman W.
    Am J Hypertens; 1998 Jan; 11(1 Pt 2):15S-22S. PubMed ID: 9503102
    [Abstract] [Full Text] [Related]

  • 37. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR.
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M, Komajda M, Torp-Pedersen C, Scherhag A, Swedberg K, Poole-Wilson PA, COMET investors.
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [Abstract] [Full Text] [Related]

  • 40. Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
    Demopoulos L, Yeh M, Gentilucci M, Testa M, Bijou R, Katz SD, Mancini D, Jones M, LeJemtel TH.
    Circulation; 1997 Apr 01; 95(7):1764-7. PubMed ID: 9107160
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.